Literature DB >> 20558763

Effects of cholesterol on CCK-1 receptors and caveolin-3 proteins recycling in human gallbladder muscle.

P Cong1, V Pricolo, P Biancani, J Behar.   

Abstract

The contraction of gallbladders (GBs) with cholesterol stones is impaired due to high cholesterol concentrations in caveolae compared with GBs with pigment stones. The reduced contraction is caused by a lower cholecystokinin (CCK)-8 binding to CCK-1 receptors (CCK-1R) due to caveolar sequestration of receptors. We aimed to examine the mechanism of cholesterol-induced sequestration of receptors. Muscle cells from human and guinea pig GBs were studied. Antibodies were used to examine CCK-1R, antigens of early and recycling endosomes, and total (CAV-3) and phosphorylated caveolar-3 protein (pCAV-3) by Western blots. Contraction was measured in muscle cells transfected with CAV3 mRNA or clathrin heavy-chain small-interfering RNA (siRNA). CCK-1R returned back to the bulk plasma membrane (PM) 30 min after CCK-8 recycled by endosomes, peaking at 5 min in early endosomes and at 20 min in recycling endosomes. Pretreatment with cholesterol-rich liposomes inhibited the transfer of CCK-1R and of CAV-3 in the endosomes by blocking CAV-3 phosphorylation. 4-Amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (inhibitor of tyrosine kinase) reproduced these effects by blocking pCAV-3 formation, increasing CAV-3 and CCK-1R sequestration in the caveolae and impairing CCK-8-induced contraction. CAV-3 siRNA reduced CAV-3 protein expression, decreased CCK-8-induced contraction, and accumulated CCK-1R in the caveolae. Abnormal concentrations of caveolar cholesterol had no effect on met-enkephalin that stimulates a delta-opioid receptor that internalizes through clathrin. We found that impaired muscle contraction in GBs with cholesterol stones is due to high caveolar levels of cholesterol that inhibits pCAV-3 generation. Caveolar cholesterol increases the caveolar sequestration of CAV-3 and CCK-1R caused by their reduced recycling to the PM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558763      PMCID: PMC2950694          DOI: 10.1152/ajpgi.00064.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  33 in total

Review 1.  The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction.

Authors:  A Schlegel; M P Lisanti
Journal:  Cytokine Growth Factor Rev       Date:  2001-03       Impact factor: 7.638

Review 2.  Clathrin-dependent or not: is it still the question?

Authors:  Ludger Johannes; Christophe Lamaze
Journal:  Traffic       Date:  2002-07       Impact factor: 6.215

Review 3.  Mechanism and consequences of delta-opioid receptor internalization.

Authors:  Daniela A Eisinger; Rudiger Schulz
Journal:  Crit Rev Neurobiol       Date:  2005

4.  Role of caveolae in the pathogenesis of cholesterol-induced gallbladder muscle hypomotility.

Authors:  Zuoliang Xiao; Frank Schmitz; Victor E Pricolo; Piero Biancani; Jose Behar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-02-15       Impact factor: 4.052

5.  Gallbladder muscle dysfunction in patients with chronic acalculous disease.

Authors:  J Amaral; Z L Xiao; Q Chen; P Yu; P Biancani; J Behar
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

Review 6.  Cholesterol and caveolae: structural and functional relationships.

Authors:  C J Fielding; P E Fielding
Journal:  Biochim Biophys Acta       Date:  2000-12-15

7.  Type-specific sorting of G protein-coupled receptors after endocytosis.

Authors:  P I Tsao; M von Zastrow
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

8.  Heterologous desensitization mediated by G protein-specific binding to caveolin.

Authors:  K S Murthy; G M Makhlouf
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

9.  Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells.

Authors:  Marpadga A Reddy; Shu-Lian Li; Saurabh Sahar; Young-Sook Kim; Zhong-Gao Xu; Linda Lanting; Rama Natarajan
Journal:  J Biol Chem       Date:  2006-03-21       Impact factor: 5.157

10.  Reactive oxygen species are messengers in maintenance of human and guinea pig gallbladder tonic contraction.

Authors:  Ping Cong; Zuo-Liang Xiao; Piero Biancani; Jose Behar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-27       Impact factor: 4.052

View more
  11 in total

1.  Rafting for gallstones by slowing mass transit.

Authors:  Nicholas O Davidson
Journal:  J Physiol       Date:  2012-05-01       Impact factor: 5.182

2.  Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease.

Authors:  B Lavoie; B Nausch; E A Zane; M R Leonard; O B Balemba; A C Bartoo; R Wilcox; M T Nelson; M C Carey; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2012-05-24       Impact factor: 3.598

Review 3.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

4.  Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis.

Authors:  Meimin Xie; Vijay R Kotecha; Jon David P Andrade; James G Fox; Martin C Carey
Journal:  J Physiol       Date:  2012-02-13       Impact factor: 5.182

Review 5.  Cholesterol gallstone disease: focusing on the role of gallbladder.

Authors:  Yongsheng Chen; Jing Kong; Shuodong Wu
Journal:  Lab Invest       Date:  2014-12-15       Impact factor: 5.662

6.  Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous "black" pigment gallstone formation in germfree Swiss Webster mice.

Authors:  Stephanie E Woods; Monika R Leonard; Joshua A Hayden; Megan Brunjes Brophy; Kara R Bernert; Brigitte Lavoie; Sureshkumar Muthupalani; Mark T Whary; Gary M Mawe; Elizabeth M Nolan; Martin C Carey; James G Fox
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

7.  Endogenous elevation of plasma cholecystokinin does not prevent gallstones.

Authors:  Rafiq A Shahid; David Q-H Wang; Brian E Fee; Shannon J McCall; Joelle M-J Romac; Steven R Vigna; Rodger A Liddle
Journal:  Eur J Clin Invest       Date:  2015-03       Impact factor: 4.686

8.  Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis.

Authors:  Kevin M Tharp; Amin Khalifeh-Soltani; Hyo Min Park; David A Yurek; Alaric Falcon; Louis Wong; Rouying Feng; Kamran Atabai; Andreas Stahl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-31       Impact factor: 4.052

9.  Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in mice.

Authors:  Guo-Qiang Xu; Cheng-Fu Xu; Hong-Tan Chen; Shan Liu; Xiao-Dong Teng; Gen-Yun Xu; Chao-Hui Yu
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

Review 10.  Recent advances in understanding and managing cholesterol gallstones.

Authors:  Agostino Di Ciaula; Piero Portincasa
Journal:  F1000Res       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.